Fortune 500 Biopharmaceutical Company Reduces Endpoint Tool Sprawl With SafeBreach

Learn how the security team at one of the largest biopharmaceutical companies in the world established continuous security control validation to ensure the most effective safeguards, while minimizing the cost, complexity, and risk of tool sprawl.

fortune_500_biopharmaceutical_tool_sprawl_reduction_safebreach_case_study